Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Science sinks its teeth into 2500 year-old drug problem

16.01.2008
A new prosthetic tooth that releases a controlled dose of medication at regular intervals may achieve a goal that has eluded doctors for 2500 years: finding a way to help patients follow treatment.

“Keep a watch also on the faults of the patients, which often make them lie about the taking of things prescribed,” warned the father of medicine, Hippocrates, 2500 years ago.

In the 1980s, Dr C Everett Koop, probably the best-known US surgeon-general, famously summarised: “Drugs don’t work in patients who don’t take them.”

Not much has changed. Studies indicate that up to 50% do not take their medicine – some forget, others deny the need for it. Still others take the wrong medication at the wrong time, or the wrong dose.

At best, it invalidates patient care. At worst, it endangers their lives. It is an intractable problem that has existed as long as medical practice.

But perhaps not for much longer. IntelliDrug, a project funded by the European Commission, has developed a system that delivers controlled drug doses at appropriate intervals, keeping the dose delivered within the exact therapeutic window. Better yet, it is easy to maintain and requires no invasive procedure.

The answer to the 2500 year-old compliance conundrum? A prosthetic tooth, just two molars in size, containing a reservoir, valve and programmable timing controls. It can even be controlled by infrared, which allows doctors to adjust doses during the course of treatment. Ultimately, it could allow patients on pain medication to self-medicate, if necessary.

Better bioavailability
“The oral cavity is very accessible, so the device can be easily installed, refilled or have its batteries replaced,” says Dr Ben Z Beiski, IntelliDrug co-inventor and project manager. “But passing the drug through the buccal (cheek) tissue also means much greater bioavailability.”

Bioavailability refers to the body’s capacity to absorb a substance. “Our evolution has designed us so that the body rejects or impedes alien substances and large, unusual molecules,” says Dr Beiski. Molecules like those, typically, that make-up many modern drugs.

The upshot is that most drugs suffer from the first-pass effect. Between stomach acid, the gastrointestinal tract and, finally, the liver much – or even all – of a given dose is eliminated before it hits the bloodstream, where it does its work. “That’s why we need intravenous injections, to avoid the first-pass effect,” explains Dr Beiski.

But IntelliDrug delivers the dose to the buccal tissue, on the inside of the cheek, where the body absorbs drug doses much more easily. Doses can be smaller and take effect quicker.

Here is how it works. The micro-system contains a reservoir and release mechanism; a programmable circuit, micro-sensors, an infrared sensor, micro-actuators and batteries. All housed in a tiny package. The circuit acts like a miniscule computer, releasing the dose required at the right time.

Ultimately, the batteries should last three months. Refilling the reservoir would vary, depending on the type of drug and dosage, but could range from every week to every month. In a later system, the team hopes to use radio-frequency identification (RFID) and later GSM telephony to communicate with the system.

It is a demonstration of the power of multidisciplinary co-operation between several scientific disciplines like micro-systems, micro-fluidics, dentistry, and pharmacy.

But does it work?
So far, the device has been tested successfully on pigs, which have similar oral characteristics. In November 2007, IntelliDrug enters human trials with twelve volunteers following naltrexone therapy, a heroin addiction treatment. If trials go well, IntelliDrug could be on the market in three years.

If successful, it could revolutionise treatment. The device can be applied to any drug, and Dr Beiski sees applications for hypertensive patients to combat morning increases in blood pressure. Chronic pain, diabetics and Alzheimer’s patients could benefit, too, making it an attractive system for patients and doctors.

For pharmaceutical companies, it is even more attractive, offering the equivalent of patent protection for generic drugs using the system. The combination would be protected by IntelliDrug intellectual property.

But perhaps most important of all, it will mean, finally, an end to the 2500 year-old patient compliance conundrum.

Christian Nielsen | alfa
Further information:
http://cordis.europa.eu/ictresults/index.cfm/section/news/tpl/article/BrowsingType/Features/ID/89269

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>